Segall Bryant & Hamill’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Sell |
42,328
-10,494
| -20% | -$4.67M | 0.26% | 127 |
|
|
2025
Q1 | $25.6M | Sell |
52,822
-3,413
| -6% | -$1.65M | 0.39% | 76 |
|
|
2024
Q4 | $22.6M | Sell |
56,235
-1,590
| -3% | -$640K | 0.31% | 100 |
|
|
2024
Q3 | $26.9M | Buy |
+57,825
| New | +$26.9M | 0.37% | 88 |
|
|
2023
Q3 | – | Sell |
-876
| Closed | -$308K | – | 700 |
|
|
2023
Q2 | $308K | Buy |
876
+14
| +2% | +$4.93K | ﹤0.01% | 638 |
|
|
2023
Q1 | $271K | Hold |
862
| – | – | ﹤0.01% | 655 |
|
|
2022
Q4 | $248K | Hold |
862
| – | – | ﹤0.01% | 673 |
|
|
2022
Q3 | $250K | Hold |
862
| – | – | ﹤0.01% | 680 |
|
|
2022
Q2 | $243K | Hold |
862
| – | – | ﹤0.01% | 689 |
|
|
2022
Q1 | $225K | Buy |
+862
| New | +$225K | ﹤0.01% | 716 |
|
|
2021
Q3 | – | Sell |
-2,385
| Closed | -$480K | – | 799 |
|
|
2021
Q2 | $480K | Buy |
2,385
+376
| +19% | +$75.7K | ﹤0.01% | 616 |
|
|
2021
Q1 | $431K | Buy |
2,009
+18
| +0.9% | +$3.86K | ﹤0.01% | 676 |
|
|
2020
Q4 | $469K | Buy |
1,991
+174
| +10% | +$41K | 0.01% | 587 |
|
|
2020
Q3 | $493K | Buy |
1,817
+946
| +109% | +$257K | 0.01% | 547 |
|
|
2020
Q2 | $253K | Hold |
871
| – | – | ﹤0.01% | 717 |
|
|
2020
Q1 | $208K | Buy |
+871
| New | +$208K | ﹤0.01% | 738 |
|
|
2018
Q4 | – | Sell |
-1,136
| Closed | -$219K | – | 882 |
|
|
2018
Q3 | $219K | Buy |
+1,136
| New | +$219K | ﹤0.01% | 808 |
|